Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Jounce Therapeutics
3203
Jounce Therapeutics
Technology
Biotechnology
Jounce Therapeutics is developing cancer immune-therapies to harness the immunesystem to attack cancerous cells and tumors.
Suggest edits
Founded
2013
Raised
$158M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Money Mover
Formlabs
Akamai
General Catalyst
Companies in the same industry
Shinom Cosmeceuticals
HVS Image
Creative Thinking Labs
BGI Tech
Bioheng
Repair Biotechnologies
Duoning Biotech
Edgewise Therapeutics
Trovant Technology
Teysha Technologies
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$102,000,000
IPO - 2017
$56,000,000
Venture capital (Series B) - 2015
Redmile Group
Foresite Capital
Wellington Management
+5
Team Size
50+
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
$102,000,000
IPO
Xconomy
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17
Stock markets
Earnings
$56,000,000
Venture capital (Series B)
VentureWire
The Daily Startup: Jounce Therapeutics Raises $56M as Immunotherapy Stays Hot
Funding
